Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials

被引：0
|
作者：
Guymer, Robyn H. [1 ]
Mitchell, Paul [2 ]
Wong, James [3 ]
Heier, Jeff [4 ]
Singh, Rishi [5 ]
Steinle, Nathan [6 ]
Boyer, David [7 ]
Mones, Jordie [8 ]
Staurenghi, Giovanni [9 ]
Holz, Frank [10 ]
Bliss, Caleb [11 ]
Deschatelets, Pascal [11 ]
Grossi, Federico [11 ]
Francois, Cedric [11 ]
Wykoff, Charlie [12 ]
Ribeiro, Ramiro [11 ]
机构：
[1] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia
[2] Sydney West Retina, Sydney, NSW, Australia
[3] Strathfield Retina Clin, Sydney, NSW, Australia
[4] Ophthalm Consultants Boston, Boston, MA USA
[5] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA
[6] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA
[7] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[8] Ctr Med Teknon, Barcelona, Spain
[9] Luigi Sacco Hosp, Milan, Italy
[10] Univ Augenklin Bonn, Bonn, Germany
[11] Apellis Pharmaceut, Waltham, MA USA
[12] Retina Consultants Texas, Dallas, TX USA
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2022年 / 49卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：833 / 833
页数：1
相关论文
共 50 条
  • [41] HOUSE DUST MITE SUBLINGUAL TABLETS: EFFICACY AND SAFETY RESULTS FROM TWO PHASE III TRIALS
    Bergmann, K.
    Relwani, K.
    Okamoto, Y.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S35 - S35
  • [42] Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration A Randomized Phase 2 Trial
    Liao, David S.
    Grossi, Federico, V
    El Mehdi, Delphine
    Gerber, Monica R.
    Brown, David M.
    Heier, Jeffrey S.
    Wykoff, Charles C.
    Singerman, Lawrence J.
    Abraham, Prema
    Grassmann, Felix
    Nuernberg, Peter
    Weber, Bernhard H. F.
    Deschatelets, Pascal
    Kim, Robert Y.
    Chung, Carol Y.
    Ribeiro, Ramiro M.
    Hamdani, Mohamed
    Rosenfeld, Philip J.
    Boyer, David S.
    Slakter, Jason S.
    Francois, Cedric G.
    OPHTHALMOLOGY, 2020, 127 (02) : 186 - 195
  • [43] Pegcetacoplan treatment meaningfully improves quality of life and fatigue in patients with paroxysmal nocturnal hemoglobinuria: results from two phase 3 clinical trials
    Kubal, T.
    Mulherin, B.
    Yeh, M.
    Al-Adhami, M.
    Savage, J.
    Dingli, D.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 468 - 469
  • [44] Efficacy and safety of satralizumab from two phase 3 trials in neuromyelitis optica spectrum disorder
    Haskova, Zdenka
    Frishberg, Benjamin
    de Seze, Jerome
    Weinshenker, Brian
    Terada, Yusuke
    Kawata, Yuichi
    Gianella-Borradori, Athos
    von Budingen, Christian
    Klingelschmitt, Gaelle
    Traboulsee, Anthony
    Yamamura, Takashi
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [45] Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials
    Federica Fogacci
    Giuseppe Danilo Norata
    Peter P. Toth
    Marcello Arca
    Arrigo F. G. Cicero
    Current Atherosclerosis Reports, 2020, 22
  • [46] Efficacy and Safety of Volanesorsen (ISIS 304801): the Evidence from Phase 2 and 3 Clinical Trials
    Fogacci, Federica
    Norata, Giuseppe Danilo
    Toth, Peter P.
    Arca, Marcello
    Cicero, Arrigo F. G.
    CURRENT ATHEROSCLEROSIS REPORTS, 2020, 22 (05)
  • [47] Alirocumab Efficacy and Safety by Race and Ethnicity: Analysis From Three ODYSSEY Phase 3 Trials
    Ferdinand, Keith C.
    Jacobson, Terry A.
    Williams, Kim A.
    Koren, Andrew T.
    Elassal, Joseph
    Thompson, Desmond E.
    Deedwania, Prakash
    CIRCULATION, 2017, 136
  • [48] Systematic Review of Safety Across the Phase 2 and 3 Clinical Trials of Intravitreal Aflibercept Injection
    Do, Diana V.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [49] Niraparib efficacy and safety in patients with BRCA-mutated (BRCAm) ovarian cancer: results from three phase 3 niraparib trials
    Gonzalez-Martin, Antonio
    Grabowski, Jacek
    Matulonis, Ursula
    Korach, Jacob
    Mirza, Mansoor
    Moore, Kathleen
    Gupta, Divya
    Lechpammer, Stanislav
    Monk, Bradley J.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 3) : 120 - 120
  • [50] Efficacy, Durability, and Safety of Faricimab in Diabetic Macular Edema: Two-Year Results from the Phase 3 YOSEMITE and RHINE Trials
    Danzig, Carl J.
    Wells, John A.
    Eichenbaum, David
    Lim, Jennifer I.
    Asik, Kemal
    Haskova, Zdenka
    Mohan, Shaun
    Silverman, David
    Tang, Yannan
    Lin, Hugh
    DIABETES, 2022, 71
12345